Production (Stage)
CYduct Diagnostics, Inc.
CYDX
$0.2521
-$0.01-3.82%
OTC PK
| 03/31/2012 | 12/31/2011 | 09/30/2011 | 06/30/2011 | 03/31/2011 | |
|---|---|---|---|---|---|
| Net Income | 125.75% | 127.32% | 131.65% | 18.96% | -71.22% |
| Total Depreciation and Amortization | -- | -100.00% | -71.43% | -33.33% | -43.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.04% | -127.48% | -37.45% | -58.66% | 133.11% |
| Change in Net Operating Assets | -355.62% | 66.99% | -243.66% | -32.00% | 636.89% |
| Cash from Operations | -3,062.86% | 75.22% | -155.17% | -214.77% | 101.83% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -193.55% | -118.77% | -1,007.69% | 91.11% | 80.63% |
| Issuance of Common Stock | 10,772.73% | -- | -- | 5.00% | -99.24% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5,625.00% | -81.14% | 142.05% | 128.57% | -101.55% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 346.67% | -103.09% | 136.21% | -365.38% | 101.70% |